Long-term Immunogenicity of Elosulfase Alfa in the Treatment of Morquio A Syndrome: Results From MOR-005, a Phase III Extension Study.
暂无分享,去创建一个
B. Schweighardt | P. Slasor | C. O’Neill | P. Harmatz | T. Tompkins | B. Long | C. Decker | L. Jesaitis | S. Khan